UK Leaders Archives -

UK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last

Clive Dix: Rebuilding UK biotech

https://pharmaphorum.com/views-and-analysis/clive-dix-rebuilding-uk-biotech/

GSK Neale Belson on building trust with employees and society

Sales and Marketing/ Views & Analysis/ Views and analysis

GSK’s Neale Belson on building trust with employees and society

George Underwood climate change, GSK, reputation, Sustainability, UK Leaders 0 Comment

Pharma’s reputation is currently riding high as the industry comes together to tackle COVID-19, but GSK’s UK general

GSK’s Neale Belson on building trust with employees and society

https://pharmaphorum.com/views-analysis-sales-marketing/gsks-neale-belson-on-building-trust-with-employees-and-society/

Market Access/ Views & Analysis/ Views and analysis

Vertex Pharma’s vision for reimbursement innovation

Paul Tunnah COVID-19, cystic fibrosis, EU Leaders, NICE, reimbursement, UK Leaders, Vertex Pharma 0 Comment

As regional vice president for Northern Europe & Australia, Simon Lem led the digital launch of Vertex Pharma’s

Vertex Pharma’s vision for reimbursement innovation

https://pharmaphorum.com/views-analysis-market-access/vertex-pharmas-vision-for-reimbursement-innovation/

Views and analysis

Ipsen’s UK & Ireland MD on adapting business to COVID-19

mike.hammerton@pharmaphorum.com business, COVID-19, Ipsen, UK, UK Leaders 0 Comment

Since entering the pharmaceutical industry as a graduate trainee in the late 1990s, Asad Mohsin Ali’s career has

Ipsen’s UK & Ireland MD on adapting business to COVID-19

https://pharmaphorum.com/views-and-analysis/ipsens-uk-md-on-adapting-business-to-covid-19/

Digital/ Market Access/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis

Novo Nordisk: Prevention, digital tools and collaboration to define the future of diabetes

George Underwood Novo Nordisk, UK Leaders 0 Comment

In our latest UK Leaders article Pinder Sahota, UK general manager at Novo Nordisk, tells us how he

Novo Nordisk: Prevention, digital tools and collaboration to define the future of diabetes

https://pharmaphorum.com/views-analysis-sales-marketing/novo-nordisk-prevention-digital-tools-and-collaboration-to-define-the-future-of-diabetes/

Market Access/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis

MSD’s David Peacock on moving UK healthcare forward

mike.hammerton@pharmaphorum.com coronavirus, COVID-19, Merck, Merck & Co, MSD, NHS, UK, UK Leaders 0 Comment

David Peacock has worked across the world for MSD and other companies, and has now taken the helm

MSD’s David Peacock on moving UK healthcare forward

https://pharmaphorum.com/views-analysis-sales-marketing/msds-david-peacock-on-moving-uk-healthcare-forward/

Market Access/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis

Teva’s Kim Innes on shaping the post-COVID future with the NHS

George Underwood coronavirus, COVID-19, generics, NHS, NICE, Teva, UK Leaders 0 Comment

Like all UK pharma GMs working during the COVID-19 pandemic, Teva’s Kim Innes has found herself leading her

Teva’s Kim Innes on shaping the post-COVID future with the NHS

https://pharmaphorum.com/views-analysis-sales-marketing/teva-kim-innes-on-shaping-the-post-covid-future-with-the-nhs/

R&D/ Views & Analysis/ Views and analysis

Janssen’s Gaëtan Leblay on leading during the COVID-19 crisis

Paul Tunnah coronavirus, COVID-19, J&J, Janssen, UK Leaders 0 Comment

COVID-19 is putting unimaginable pressure on healthcare systems and the companies looking for solutions to end the pandemic.

Janssen’s Gaëtan Leblay on leading during the COVID-19 crisis

https://pharmaphorum.com/r-d/views-analysis-r-d/janssens-gaetan-leblay-on-leading-during-the-covid-19-crisis/

Market Access/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis

Daiichi Sankyo: pharma needs to become NHS ‘experts’

George Underwood Daiichi Sankyo, NHS, pricing, UK Leaders 0 Comment

If pharma wants to help the NHS improve outcomes, it needs to do so through a true partnership

Daiichi Sankyo: pharma needs to become NHS ‘experts’

https://pharmaphorum.com/views-analysis-market-access/daiichi-sankyo-pharma-needs-to-become-nhs-experts/

Trending

UK Leaders

Login